Chrysa Oikonomou

Clinical associations and classification of immune checkpoint inhibitor-induced cutaneous toxicities: a multicentre study from the European Academy of Dermatology and Venereology Task Force of Dermatology for Cancer Patients

Vasiliki Nikolaou, Zoé Apalla, Cristina Carrera et al. · British Journal of Dermatology · 2022 · 42 citations · Full text

Medicine, Dermatology, Oncology +17

Deregulation of methylation of transcribed-ultra conserved regions in colorectal cancer and their value for detection of adenomas and adenocarcinomas

Anna G. Antonacopoulou, Foteinos‐Ioannis Dimitrakopoulos, Chaido Sirinian et al. · Oncotarget · 2018 · 15 citations · Full text

Medicine, Molecular Biology, Oncology +17

A real‐world, non‐interventional, prospective study of the effectiveness and safety of apremilast in bio‐naïve adults with moderate plaque psoriasis treated in the routine care in Greece – the ‘<scp>APRAISAL</scp>’ study

D. Ioannides, Nikolaos Antonakopoulos, Vasiliki Chasapi et al. · Journal of the European Academy of Dermatology and Venereology · 2022 · 10 citations

Medicine, Dermatology, Pharmacotherapy +12

Use of omalizumab is associated with improvement of pruritic skin disorders induced by immune checkpoint inhibitors: A retrospective cohort from the European Task Force of Dermatology for Cancer patients

Francesc Alamón‐Reig, Xavier Bosch‐Amate, Priscila Giavedoni et al. · Journal of the American Academy of Dermatology · 2023 · 10 citations · Full text

Medicine, Dermatology, Immunology +17